Recombinant Anti-IL23 x Anti-IL6 Bispecific Antibody (CrossMab) (CROSSAB-178)

Recombinant Anti-IL23 x Anti-IL6 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Inflammatory diseases therapy.

Datasheet INQUIRY

Specifications

Targets

IL23 & IL6

Type

CrossMab

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Inflammatory diseases

Targets

Target 1

IL23

Gene ID

51561

UniProt ID

Q9NPF7

Alternative Names

P19; SGRF; IL-23; IL-23A; IL23P19; Interleukin-23; IL23; interleukin 23 subunit alpha

Target 2

IL6

Gene ID

3569

UniProt ID

P05231

Alternative Names

CDF; HGF; HSF; BSF2; IL-6; BSF-2; IFNB2; IFN-beta-2; interleukin 6; IL6

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL23 x Anti-IL6 Bispecific Antibody (CrossMab) (CROSSAB-178). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-IL23 x Anti-IL6 Bispecific Antibody (CrossMab) (CAT#: CROSSAB-178)

Specifications

Targets

Customer Reviews and Q&As